BIOSIMILAR INFLIXIMAB IS EFFECTIVE AND SAFE IN INFLAMMATORY BOWEL DISEASE PATIENTS NAIVE TO ANTI-TNF THERAPY: A TERTIARY CENTER EXPERIENCE
Martin Bortlík 1
Martin Kolar 1
Dana Duricova 1
Karin Malíčková 2
Veronica Hruba
Nadezda Machkova
Katarina Mitrova
Martin Lukas
Milan Lukas
1 ISCARE I.V.F. a.s., IBD Clinical and Research Center, Prague, Czech Republic
2 Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Medical Faculty and General Teaching H
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing